Testosterone treament advances at Raleigh pharma startup led by former GSK execs
by Barry Teater, NCBiotech writer — January 6, 2021 . RESEARCH TRIANGLE PARK – Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug. Marius has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of Kyzatrex, its novel treatment for hypogonadism, or testosterone deficiency, in men. “Submission of our first NDA is an important milestone, bringing attention to the role of testosterone as a critical hormone and the multitude of effects it can ...
Source: wraltechwire.com